We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson, Columbia CRL Could Be Game Changer, Company Official Says
Watson, Columbia CRL Could Be Game Changer, Company Official Says
March 2, 2012
In a regulatory rejection decried as a potential industry game-changer, Columbia Laboratories and Watson Pharmaceuticals have received a complete response letter from the FDA for their progesterone vaginal gel citing a lack of agency confidence in Columbia’s sole late-stage trial.